Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Brain and Acute Leukemia, Cytoplasmic (BAALC) Peptide

BAALC Reactivité: Humain, Souris Hôte: Synthetic BP, BI
N° du produit ABIN5684841
  • Antigène Tous les produits BAALC
    BAALC (Brain and Acute Leukemia, Cytoplasmic (BAALC))
    Origine
    Humain, Souris
    Source
    • 1
    Synthetic
    Application
    Blocking Peptide (BP), BioImaging (BI)
    Attributs du produit
    BAALC peptide corresponds to 15 amino acids of BAALC.
  • Indications d'application
    BAALC Peptide is used for blocking the activity of BAALC antibody . The BAALC antibody ships at 0.5 mg/mL and the BAALC Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    BAALC peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
    Stock
    -20 °C
    Stockage commentaire
    Store at -20°C. When reconstituted minimize freezing and thawing.
  • Antigène
    BAALC (Brain and Acute Leukemia, Cytoplasmic (BAALC))
    Synonymes
    si:zc215i13.3 Peptide, si:ch211-215i13.3 Peptide, BAALC Peptide, 2810457D07Rik Peptide, BAALC, MAP3K1 and KLF4 binding Peptide, brain and acute leukemia, cytoplasmic Peptide, BAALC Peptide, baalc Peptide, Baalc Peptide
    ID gène
    79870
    NCBI Accession
    NP_079088
    OMIM
    13376200
    UniProt
    Q8WXS3
Vous êtes ici:
Support technique